QSAR modeling, molecular docking and ADMET/pharmacokinetic studies: a chemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic drugs
Open Access
- 10 April 2020
- journal article
- research article
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 17 (8) , 1953-1966
Abstract
Chemometrics study that relates biological activity to physicochemical descriptors of a molecule and the prediction of absorption, distribution, metabolism, excretion and toxicity (ADMET) properties in advance are important steps in drugs discovery. In this study, a chemometrics approach was employed on some molecules (inhibitors) of norepinephrine transporter to assess their inhibitory potencies, interactions with the receptor and predict their ADMET/pharmacokinetic properties for identification of novel antipsychotic drugs. The molecules were optimized by using density functional theory at the basis set of B3LYP/6-31G*. The genetic function algorithm technique was used to generate a statistically significant model with a good correlation coefficient R2Train = 0.952 Cross-validated coefficient Q2cv = 0.870, and adjusted squared correlation coefficient R2adj = 0.898. The molecular docking simulation using a neurotransmitter transporter receptor (PDB Code 2A65) revealed that three inhibitors (molecule No 38, 44 and 12) exhibited the highest binding affinity of − 10.3, − 9.9 and − 9.3 kcal/mol, respectively, were observed to inhibit the target by forming strong hydrogen bonds with hydrophobic interactions. The physicochemical and ADMET/pharmacokinetic properties result showed that these three molecules are orally bioavailable, high gastrointestinal absorption, good permeability and non-inhibitors of CYP3A4 and CYP2D6 except for molecule No 38. Also, Molecules No 38 and 44 proved to be non-substrate of P-glycoprotein and nontoxicity to a human ether-a-go-go-related gene with predicted hERG toxicity endpoints (pIC50 < 6) and low ADMET_Risk (< 7.0). The results of this study would provide physicochemical and pharmacokinetics properties needed to identify potent antipsychotic drugs and other relevant information in drug discovery.Keywords
This publication has 35 references indexed in Scilit:
- An Integrated Transfer Learning and Multitask Learning Approach for Pharmacokinetic Parameter PredictionMolecular Pharmaceutics, 2018
- What Contributes to Serotonin–Norepinephrine Reuptake Inhibitors’ Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics SimulationACS Chemical Neuroscience, 2018
- Monoamine transporters: insights from molecular dynamics simulationsFrontiers in Pharmacology, 2015
- QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ)European Journal of Pharmaceutical Sciences, 2015
- X-ray structure of dopamine transporter elucidates antidepressant mechanismNature, 2013
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disorders, 2009
- QSAR study on dual SET and NET reuptake inhibitors: An insight into the structural requirement for antidepressant activityJournal of Enzyme Inhibition and Medicinal Chemistry, 2008
- Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001Neurosurgical Focus, 2006
- Health economics and cost implications of anxiety and other mental disorders in the United StatesThe British Journal of Psychiatry, 1998
- Treatment of electronic excitations within the adiabatic approximation of time dependent density functional theoryChemical Physics Letters, 1996